Literature DB >> 25804401

Guidelines for cytogenetic investigations in tumours.

Rosalind J Hastings1, Nick Bown2, Maria G Tibiletti3, Maria Debiec-Rychter4, Roberta Vanni5, Blanca Espinet6, Nadine van Roy7, Paul Roberts8, Eva van den Berg-de-Ruiter9, Alain Bernheim10, Jacqueline Schoumans11, Steve Chatters12, Zuzana Zemanova13, Marian Stevens-Kroef14, Annet Simons14, Sverre Heim15, Marta Salido6, Bauke Ylstra16, David R Betts17.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25804401      PMCID： PMC4795217          DOI： 10.1038/ejhg.2015.35

Source DB:  PubMed          Journal:  Eur J Hum Genet        ISSN： 1018-4813            Impact factor:   4.246


× No keyword cloud information.
  19 in total

1.  Targeted sequencing by proximity ligation for comprehensive variant detection and local haplotyping.

Authors:  Paula J P de Vree; Elzo de Wit; Mehmet Yilmaz; Monique van de Heijning; Petra Klous; Marjon J A M Verstegen; Yi Wan; Hans Teunissen; Peter H L Krijger; Geert Geeven; Paul P Eijk; Daoud Sie; Bauke Ylstra; Lorette O M Hulsman; Marieke F van Dooren; Laura J C M van Zutven; Ans van den Ouweland; Sjef Verbeek; Ko Willems van Dijk; Marion Cornelissen; Atze T Das; Ben Berkhout; Birgit Sikkema-Raddatz; Eva van den Berg; Pieter van der Vlies; Desiree Weening; Johan T den Dunnen; Magdalena Matusiak; Mohamed Lamkanfi; Marjolijn J L Ligtenberg; Petra ter Brugge; Jos Jonkers; John A Foekens; John W Martens; Rob van der Luijt; Hans Kristian Ploos van Amstel; Max van Min; Erik Splinter; Wouter de Laat
Journal:  Nat Biotechnol       Date:  2014-08-17       Impact factor: 54.908

Review 2.  Biological and therapeutic impact of intratumor heterogeneity in cancer evolution.

Authors:  Nicholas McGranahan; Charles Swanton
Journal:  Cancer Cell       Date:  2015-01-12       Impact factor: 31.743

Review 3.  Focal chromosomal copy number aberrations in cancer-Needles in a genome haystack.

Authors:  Oscar Krijgsman; Beatriz Carvalho; Gerrit A Meijer; Renske D M Steenbergen; Bauke Ylstra
Journal:  Biochim Biophys Acta       Date:  2014-08-07

4.  Analyzing cancer samples with SNP arrays.

Authors:  Peter Van Loo; Gro Nilsen; Silje H Nordgard; Hans Kristian Moen Vollan; Anne-Lise Børresen-Dale; Vessela N Kristensen; Ole Christian Lingjærde
Journal:  Methods Mol Biol       Date:  2012

5.  Analysis of HER-2/neu amplification in endometrial carcinoma by chromogenic in situ hybridization. Correlation with fluorescence in situ hybridization, HER-2/neu, p53 and Ki-67 protein expression, and outcome.

Authors:  G Peiró; D Mayr; P Hillemanns; U Löhrs; J Diebold
Journal:  Mod Pathol       Date:  2004-03       Impact factor: 7.842

Review 6.  Expanding the computational toolbox for mining cancer genomes.

Authors:  Li Ding; Michael C Wendl; Joshua F McMichael; Benjamin J Raphael
Journal:  Nat Rev Genet       Date:  2014-07-08       Impact factor: 53.242

7.  Comparison of targeted next-generation sequencing (NGS) and real-time PCR in the detection of EGFR, KRAS, and BRAF mutations on formalin-fixed, paraffin-embedded tumor material of non-small cell lung carcinoma-superiority of NGS.

Authors:  Katja Tuononen; Satu Mäki-Nevala; Virinder Kaur Sarhadi; Aino Wirtanen; Mikko Rönty; Kaisa Salmenkivi; Jenny M Andrews; Aino I Telaranta-Keerie; Sari Hannula; Sonja Lagström; Pekka Ellonen; Aija Knuuttila; Sakari Knuutila
Journal:  Genes Chromosomes Cancer       Date:  2013-01-30       Impact factor: 5.006

Review 8.  Technical and implementation issues in using next-generation sequencing of cancers in clinical practice.

Authors:  D Ulahannan; M B Kovac; P J Mulholland; J-B Cazier; I Tomlinson
Journal:  Br J Cancer       Date:  2013-07-25       Impact factor: 7.640

9.  DNA copy number analysis of fresh and formalin-fixed specimens by shallow whole-genome sequencing with identification and exclusion of problematic regions in the genome assembly.

Authors:  Ilari Scheinin; Daoud Sie; Henrik Bengtsson; Mark A van de Wiel; Adam B Olshen; Hinke F van Thuijl; Hendrik F van Essen; Paul P Eijk; François Rustenburg; Gerrit A Meijer; Jaap C Reijneveld; Pieter Wesseling; Daniel Pinkel; Donna G Albertson; Bauke Ylstra
Journal:  Genome Res       Date:  2014-09-18       Impact factor: 9.043

10.  Next generation sequencing and tumor mutation profiling: are we ready for routine use in the oncology clinic?

Authors:  Debu Tripathy; Kathleen Harnden; Kimberly Blackwell; Mark Robson
Journal:  BMC Med       Date:  2014-08-12       Impact factor: 8.775
View more
  11 in total

1.  Definition of MYC genetic heteroclonality in diffuse large B-cell lymphoma with 8q24 rearrangement and its impact on protein expression.

Authors:  Alexandra Valera; Samantha Epistolio; Lluis Colomo; Alice Riva; Olga Balagué; Ivan Dlouhy; Alexandar Tzankov; Marco Bühler; Eugenia Haralambieva; Elias Campo; Davide Soldini; Luca Mazzucchelli; Vittoria Martin
Journal:  Mod Pathol       Date:  2016-04-29       Impact factor: 7.842

2.  c-MYC amplification and c-myc protein expression in pancreatic acinar cell carcinomas. New insights into the molecular signature of these rare cancers.

Authors:  Stefano La Rosa; Barbara Bernasconi; Alessandro Vanoli; Amedeo Sciarra; Kenji Notohara; Luca Albarello; Selenia Casnedi; Paola Billo; Lizhi Zhang; Maria Grazia Tibiletti; Fausto Sessa
Journal:  Virchows Arch       Date:  2018-05-02       Impact factor: 4.064

3.  A novel next generation sequencing approach to improve sarcoma diagnosis.

Authors:  Lauren McConnell; Oisín Houghton; Peter Stewart; Jana Gazdova; Shambhavi Srivastava; Chang Kim; Mark Catherwood; Anna Strobl; Adrienne M Flanagan; Anca Oniscu; Leonie I Kroeze; Patricia Groenen; Philippe Taniere; Manuel Salto-Tellez; David Gonzalez
Journal:  Mod Pathol       Date:  2020-02-11       Impact factor: 7.842

4.  FrenchFISH: Poisson Models for Quantifying DNA Copy Number From Fluorescence In Situ Hybridization of Tissue Sections.

Authors:  Geoff Macintyre; Anna M Piskorz; Adam Berman; Edith Ross; David B Morse; Ke Yuan; Darren Ennis; Jeremy A Pike; Teodora Goranova; Iain A McNeish; James D Brenton; Florian Markowetz
Journal:  JCO Clin Cancer Inform       Date:  2021-02

5.  Signatures of Discriminative Copy Number Aberrations in 31 Cancer Subtypes.

Authors:  Bo Gao; Michael Baudis
Journal:  Front Genet       Date:  2021-05-13       Impact factor: 4.599

6.  Genetic Heterogeneity of HER2 Amplification and Telomere Shortening in Papillary Thyroid Carcinoma.

Authors:  Paola Caria; Silvia Cantara; Daniela Virginia Frau; Furio Pacini; Roberta Vanni; Tinuccia Dettori
Journal:  Int J Mol Sci       Date:  2016-10-21       Impact factor: 5.923

Review 7.  Use of Fluorescence In Situ Hybridization (FISH) in Diagnosis and Tailored Therapies in Solid Tumors.

Authors:  Natalia Magdalena Chrzanowska; Janusz Kowalewski; Marzena Anna Lewandowska
Journal:  Molecules       Date:  2020-04-17       Impact factor: 4.411

8.  Prognostic relevance of CD163 and CD8 combined with EZH2 and gain of chromosome 18 in follicular lymphoma: a study by the Lunenburg Lymphoma Biomarker Consortium.

Authors:  Wendy B C Stevens; Matias Mendeville; Robert Redd; Andrew J Clear; Reno Bladergroen; Maria Calaminici; Andreas Rosenwald; Eva Hoster; Wolfgang Hiddemann; Philippe Gaulard; Luc Xerri; Gilles Salles; Wolfram Klapper; Michael Pfreundschuh; Andrew Jack; Randy D Gascoyne; Yasodha Natkunam; Ranjana Advani; Eva Kimby; Birgitta Sander; Laurie H Sehn; Anton Hagenbeek; John Raemaekers; John Gribben; Marie José Kersten; Bauke Ylstra; Edie Weller; Daphne de Jong
Journal:  Haematologica       Date:  2017-04-14       Impact factor: 9.941

9.  EBV⁺ and MSI Gastric Cancers Harbor High PD-L1/PD-1 Expression and High CD8⁺ Intratumoral Lymphocytes.

Authors:  Simona De Rosa; Nora Sahnane; Maria Grazia Tibiletti; Francesca Magnoli; Alessandro Vanoli; Fausto Sessa; Anna Maria Chiaravalli
Journal:  Cancers (Basel)       Date:  2018-04-01       Impact factor: 6.639

Review 10.  Cytogenetic and Biochemical Genetic Techniques for Personalized Drug Therapy in Europe.

Authors:  Tatjana Huebner; Catharina Scholl; Michael Steffens
Journal:  Diagnostics (Basel)       Date:  2021-06-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.